As another cannabis earnings season comes to a close, the financial results from some of the smaller U.S. multi-state operators (MSOs) have fallen under the radar, despite posting awe-inspiring numbers.... read more →
Hollister Biosciences Also Provided a Corporate Update on the Company's Business Operations During the Coronavirus Pandemic Thanks to Cannabis Being Deemed Essential in the States Hollister Operates In, the Company... read more →
Welcome to the Cannabis Countdown. In this week’s rendition, we’ll recap and countdown the top 10 Marijuana and Psychedelic stock news stories for the week of April 20th – 26th, 2020.... read more →
Carl Saling, CEO of Hollister Biosciences (CSE: HOLL) (OTC: HSTRF) (FRA: HOB) and Venom Extracts CEO Mason Cave sat down with TCI host Alyssa Boston (Miss Universe Canada 2019 +... read more →
Hollister Biosciences is on a Roll, and the Investing Community is Finally Giving the Company the Attention it Rightfully Deserves Since Bottoming at the Start of April, HOLL Stock Has... read more →
Welcome to the Cannabis Countdown. In this week’s rendition, we’ll recap and countdown the top 10 Marijuana and Psychedelic Stock News stories for the week of March 30th – April 5th,... read more →
The Highly Accretive Acquisition Strengthens Hollister's Brand Portfolio While Expanding its Footprint Across Multiple U.S. States Venom Extracts Brings With it 2019 EBITDA of $2.5 Million on Revenue of $16.4... read more →
Hollister Biosciences Signs LOI to Acquire Venom Extracts, One of Arizona's Premier Cannabis Extract and Distillate Brands The Award-Winning Venom Extracts Generated EBITDA of $2.48 Million on Revenue of $16.4... read more →
